7 min ago | The Jersey Journal
Bristol-Myers Squibb drug study showed effectiveness against advanced melanoma cancer
Two drugs from Bristol-Myers Squibb Co. shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.
4 hrs ago | Mother Jones
Taxpayer Dollars Are Helping Monsanto Sell Seeds Abroad
Nearly two decades after their mid-'90s debut in US farm fields, GMO seeds are looking less and less promising.
8 hrs ago | Bioscience Technology
Maturing Teenage Brain Explored
Despite adolescence being a high-risk time for developing major psychiatric and drug dependence disorders, very little is known about the teenage brain.
J&J to stop selling metal-on-metal hip replacements, citing drop in demand
Johnson & Johnson, the world's biggest maker of health-care products, said it will stop selling metal-on-metal and ceramic-on-metal hip replacements as demand wanes for the devices and U.S. regulators seek new rules.
Parents see more food, skin allergies in kids
Parents are reporting more skin and food allergies in their children, a big government survey found.
Merck KGaA Rating Reiterated by Societe Generale
They currently have a 101.00 price target on the stock. Shares of Merck KGaA traded up 0.13% during mid-day trading on Wednesday, hitting 119.00. Merck KGaA has a 52 week low of 72.51 and a 52 week high of 125.525. The stock's 50-day moving average is currently 94.50. MRK has been the subject of a number of other recent research reports.
Child mental health disorders rising, cost society $247 billion annually
And the rate is increasing, said the U.S. Centers for Disease Control and Prevention, which produced the study, released Thursday.
Esperion Therapeutics seeking $70 million in IPO filing
In documents filed Tuesday with the U.S. Securities and Exchange Commission , the company declared that it is setting a $70 million goal for the initial public offering and will be traded on the Nasdaq Stock Market under the symbol ESPR .
Five lessons in corporate brand building from the big boys
Research by media monitoring company Precise, published in March 2013 says that consumers are more likely to view FMCG companies favourably if they develop a recognisable corporate brand.
Merck & Co., Inc. (MRK), Seadrill Ltd (SDRL), Banco Santander, S.A....
Every quarter, many money managers have to disclose what they've bought and sold, via "13F" filings.
The Latest News In Biotech And Comedian Paul Reiser
New News In Biotechnology The American Society of Clinical Oncology conference is convening in two weeks.
Study: Women Could Live Longer Than Men Due To Better Immune System
The Centers for Disease Control and Prevention in Atlanta states that the human immune system, also referred to as the Lymphatic system, is the body's first line of defense against infections and disease.
Criminal fraud at an Indian drug company
On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi.
Abandoned Boat Found in La Jolla
San Diego Lifeguards say the 19 foot Bayliner was spotted at the end of Nautilus Street around 5:45 a.m. There were six life jackets spotted in the area a few yards away from the boat but no one is in the area officials said.
'Ranbaxy Resolves Criminal and Civil Charges Through Record Settlement'
On May 13, 2013, generic drug manufacturer Ranbaxy USA Inc. , a subsidiary of Indian generic drug manufacturer Ranbaxy Laboratories Limited, pled guilty to seven felony charges as part of a global settlement pursuant to which Ranbaxy will pay a total of $500 million to resolve criminal and civil False Claims Act liability.
States Brace for Monsanto's 'Big Stick' in GMO Labeling Fight
Grassroots groups across the United States are mobilizing against the nation's powerful biotech firms as a new round of labeling laws for foods made with genetically modified organisms make their way through state legislatures.
Will Angelina Jolie Announcement Boost Biotech Stocks?
While Angelina Jolie's announcement on Tuesday that she had a double mastectomy after learning she carried a genetic predisposition for breast cancer raised awareness about genetic testing, analysts are skeptical that it will boost the stock prices in the biotech industry.
Midlife and Suicide: Why Are We Killing Ourselves?
May is Mental Health Month. Our collective mental health is a crucial topic for us to discuss all the time.
Online Health Assessment Urged For Baby Boomers
Tennessee health officials are urging people to take a five-minute online assessment about whether they are at risk for hepatitis C. Tennessee Department of Health Commissioner John Dreyzehner said baby boomers are five time more likely than the general population to have the disease.
3 Biotech Stocks With Potential
Biotechnology companies offer the opportunity to achieve lofty returns but also have the potential for complete failure.